INNOCAN PHARMA Corp
INNPF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $52 | $23 | $37 | $44 |
| - Cash | $7 | $7 | $6 | $5 |
| + Debt | $2 | $1 | $1 | $0 |
| Enterprise Value | $47 | $17 | $32 | $39 |
| Revenue | $7 | $7 | $8 | $5 |
| % Growth | -3.7% | -10.1% | 44.3% | – |
| Gross Profit | $6 | $6 | $7 | $4 |
| % Margin | 90.8% | 88.4% | 91.3% | 81.6% |
| EBITDA | -$1 | -$0 | $0 | $0 |
| % Margin | -20.8% | -1.4% | 0.6% | 0.2% |
| Net Income | -$2 | -$1 | -$1 | -$0 |
| % Margin | -28.9% | -8.4% | -7.5% | -2.1% |
| EPS Diluted | -0.43 | -0.13 | -0.13 | -0.026 |
| % Growth | -230.8% | 0% | -400% | – |
| Operating Cash Flow | $0 | $1 | $0 | -$1 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $1 | $0 | -$1 |